Public Workshop: Safety Assessment for Investigational New Drug Reporting March 8, 2018 - 9:00 am to 4:00 pm Council on Foreign Relations 1777 F Street NW Washington, DC 20006 This public workshop, convened under a cooperative agreement with the Food and Drug...
Public Workshop: Strategies for Promoting the Safe Use and Appropriate Prescribing of Prescription Opioids February 15, 2018 - 9:00 am to 4:30 pm National Press Club 529 14th Street NW, 13th Floor Washington, DC 20045 The current opioid epidemic remains a major public health crisis. In response to growing rates...
Assessing the Public Health Impact of Prescription Drug Postmarketing Safety Labeling Changes February 8, 2018 - 9:00 am to 4:00 pm Duke-Margolis Center for Health Policy 1201 Pennsylvania Avenue NW, Suite 500Washington, DC. 20004 When FDA identifies potential safety concerns with a medical product already on the market, it...
2018 Sentinel Initiative Annual Public Workshop February 7, 2018 - 9:00 am Hyatt Regency Bethesda 1 Bethesda Metro Center Bethesda, MD 20814 This annual workshop serves as a forum to bring together leading experts and interested...
Public Workshop: Oncology Clinical Trials in the Presence of Non-Proportional Hazards February 5, 2018 - 9:00 am to 4:30 pm National Press Club The National Press Club 529 14th St. NW, 13th Floor Washington, DC 20045 Convened by the Duke-Robert J. Margolis, MD, Center for Health Policy at Duke University and...
FDA’s New Regulatory Framework for Tobacco and Nicotine: the Role of Medicinal Nicotine December 12, 2017 - 12:30 pm National Press Club 529 14th Street NW Washington, DC 20045 The U.S. Food and Drug Administration (FDA) recently announced a new, comprehensive regulatory...
Advancing Structured Benefit-Risk Assessment in FDA Review October 4, 2017 (All day) The Duke-Margolis Center for Health Policy 1201 Pennsylvania Avenue, NW, 5th Floor, Washington, DC 20004 As part of a broader effort to increase the predictability, transparency, and efficiency of its...
Exploring Approaches for Value-based Reimbursement of Oncology Therapies October 3, 2017 (All day) Duke-Margolis Center for Health Policy 1201 Pennsylvania Avenue NW, Suite 500 Washington, DC. 20004 Advances in cancer care have resulted in significant improvement in patient outcomes, but... Biomedical InnovationHealthcare Transformation
Public Event: Mobilizing mHealth Innovation for Real-World Evidence Generation September 15, 2017 - 2:00 pm to 4:00 pm Duke-Margolis Center for Health Policy Ground Floor Conference Room 1201 Pennsylvania Avenue, NW Washington, DC 20004 Webcast available, please register through the link above. As consumers embrace new technologies as part of their... Biomedical Innovation
Public Workshop: A Framework for Regulatory Use of Real-World Evidence September 13, 2017 - 9:00 am to 4:00 pm 1777 F Street Conference Center 1777 F Street NW Washington, DC 20006 The Duke-Margolis Center would like to continue to solicit feedback on the white paper and its...
